The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Praxis Precision Medicines, Inc(NASDAQ:PRAX)


Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in...
Website: http://www.praxismedicines.com
Founded: 2015
Full Time Employees: 50
CEO: Marcio Souza
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Praxis Precision Medicines Days Payable Outstanding ttm (DPO)
Praxis Precision Medicines Op Cashflow Per Share ttm
Praxis Precision Medicines Free Cashflow Per Share ttm
Praxis Precision Medicines Cash Per Share ttm
Praxis Precision Medicines P/S ratio ttm
Praxis Precision Medicines (GAAP) P/E ratio ttm
Praxis Precision Medicines P/B ratio ttm
No extra charts and metrics for this ticker.